Therapeutic Goods Administration

Some biocidal surfactants, which are used as disinfectants or sterilants, come under the control of the TGA. These types of products are regulated as medical devices (Therapeutics Goods Order No, 54 (Standard for disinfectants and sterilants) (TG054) [15]. 

The functions of the TGA will be transferred to a new Australia/New Zealand joint agency called the Trans-Tasman Joint Agency for Therapeutic Goods in the near future. 

---

Therapeutic Goods Administration oniy. Cuba does not have a private sector. 

All clinical trials must be notified to the Therapeutic Goods Administration. 

The number of staff working in these laboratories varies greatly, ranging from as few as four full-time posts (actually two full-time and four part-time staff) in the mini-lab in Uganda, to as many as 131.5 full-time posts (actually 129 full-time and five part-time staff) working for the Therapeutic Goods Administration Laboratory (TGAL) in Australia. 

TGAL Therapeutic Goods Administration Laboratory (Australia)... 

Australia s Therapeutic Goods Administration (TGA) has perhaps one of the most progressive and comprehensive regulatory systems in the world. Under the Therapeutic Goods Act, the TGA regulates prescription medicines, OTC... 

Australia s Therapeutic Goods Administration website, http //www.tga.gov.au/ [accessed July 29,2007]. 

Some regulatory authorities have foreseen the future impact of TM and set up appropriate guidelines. The European Union has legislation for traditional herbal products. Another example is the Therapeutic Goods Administration of Australia, which has set up a complementary medicine section that controls the regulatory practices for TM. 

The Therapeutic Goods Administration (TG A), as part of the Commonwealth Department of Health, has the responsibihty for administering the Act. It applies a risk management approach to therapeutic goods regulation, which is intended to ensure public health and safety while minimising the regulatory burden and associated costs. 

Therapeutic Goods Administration Laboratories of Australia (TGAL) (1990), Guidelines for Assessing the Results of Microbiological Tests on Nonsterile Pharmaceuticals for Human Use, TGAL, Canberra, Australia. 

Valeriana officinalis L. is acceptable as an active ingredient in the listed products category of the Therapeutic Goods Administration... 

The importation and manufacture of new chemicals in Australia is regulated under Industrial Chemicals (Notification and Assessment) Act 1989 [1] which is administered by National Industrial Notification and Assessment Scheme (NICNAS) [2 ]. NICNAS was operated within the National Occupational Health and Safety Commission until November 2001, when it was transferred to the Therapeutic Goods Administration (TGA). 

Cosmetic ingredients National Industrial Chemicals Notification and Assessment Scheme (NICNAS) National Drugs and Poisons Scheduling Committee (NDPC) Australian Consumer and Competition Commission (ACCC) Therapeutic Goods Administration (TGA) State Health Departments... 

Therapeutic goods (drugs and devices) Therapeutic Goods Administration (TGA) Approvals at Federal level... 

Khat has been recognized as a substance of abuse with increasing popularity. It is estimated that 10 million people chew khat worldwide, and it is used by up to 80% of adults in Somalia and Yemen. It now extends to immigrant African communities in the UK and USA. It is banned in Saudi Arabia, Egypt, Morocco, Sudan, and Kuwait. It is also banned in the USA and European countries. However, in Australia, its importation is controlled by a licence issued by the Therapeutic Goods Administration, which allows up to 5 kg of khat per month per individual for personal use. 

TGA (1990), Australian Code of Good Manufacturing for Therapeutic Goods, Medicinal Products — Part 1, Therapeutic Goods Administration, Wooden, Australia. 

The pharmacopeial standard applying to sterile products is that they must be capable of passing a Test for Sterility. A Test for Sterility is described in U.S. Pharmacopeia (USP) under Section 71 and in the European Pharmacopoeia (PhEur) under Section 2.6.1. These were harmonized along with the Japanese Pharmacopoeia and the requirements of the Australian Therapeutic Goods Administration in 1999, but they still have some minor differences in detail. 

The product Longdan Qiegan Wan ( Wetness Heat Pill) was removed from the Austrahan Register of Therapeutic Goods following the detection of aristolochic acid by laboratory testing by the Therapeutic Goods Administration (3). 

---